Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec;28(4):234-46.
doi: 10.1055/s-0035-1564431.

Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal Chemotherapy

Ashlie Nadler  1 , J Andrea McCart  1 , Anand Govindarajan  1
Affiliations
Review

Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal Chemotherapy

Ashlie Nadler et al. Clin Colon Rectal Surg. 2015 Dec.

Abstract

A systematic review of the literature on the management of peritoneal carcinomatosis (PC) from colon cancer with cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) was undertaken using OVID Medline. Forty-six relevant studies were reviewed. Mean weighted overall morbidity following CRS and IPC was 49% (range 22-76%) and mortality was 3.6% (range 0-19%). Median overall survival ranged from 15 to 63 months, and 5-year overall survival ranged from 7 to 100%. This represents an improvement over historical treatment with systemic chemotherapy alone, even in the era of modern chemotherapeutic agents. Quality of life following surgery is initially decreased but improves with time and approaches baseline. Available data appear to support the treatment of PC from colon cancer with CRS and IPC. There is a large amount of variability among studies and few high-quality studies exist. Further studies are needed to standardize techniques.

Keywords: carcinomatosis; colorectal cancer; intraperitoneal chemotherapy; outcomes.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Peritoneal Cancer Index (PCI) calculation for patients with peritoneal carcinomatosis.
See this image and copyright information in PMC

References

    1. Jayne D G, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89(12):1545–1550. - PubMed
    1. Glehen O Osinsky D Beaujard A C Gilly F N Natural history of peritoneal carcinomatosis from nongynecologic malignancies Surg Oncol Clin N Am 2003123729–739., xiii - PubMed
    1. Sugarbaker P H, Cunliffe W J, Belliveau J. et al.Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol. 1989;16(4) 06:83–97. - PubMed
    1. Minsky B D, Mies C, Rich T A, Recht A, Chaffey J T. Potentially curative surgery of colon cancer: patterns of failure and survival. J Clin Oncol. 1988;6(1):106–118. - PubMed
    1. Verwaal V J, van Ruth S, de Bree E. et al.Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737–3743. - PubMed